Evaluation of cyclin expression in testicular germ cell tumors: Cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis

Modern Pathology

Volumn 13, Issue 6, 2000, Pages 667-672

  Datta, Milton W ^a   Renshaw, Andrew A ^b   Dutta, Anindya ^b   Hoffman, Michael A ^b   Loughlin, Kevin R ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cyclin A; Cyclin E; Germ cell tumor; Ki 67; Lmmunohistochemistry; Testis

Indexed keywords

CYCLIN A; CYCLIN E; KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 0033917330     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880117     Document Type: Article

References (22)

1. Albers P, Bierhoff E, Neu D, Fimmers R, Wernert N, Muller SC. MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer 1997;79:1710-6.
2. Heidenreich A, Schenkmann NS, Sestcrhenn IA, Mostofi FK, McCarthy WF, Heidenreich B, et al. Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors. J Urol 1997;158:620-5.
3. Hori K, Uematsu K, Yasoshima H, Sakurai K, Yamada A. Contribution of cell proliferative activity to malignancy potential in testicular seminoma. Pathol Int 1997;47:282-7.
4. Gillett CE, Barnes DM. Demystified . . . cell cycle. Mol Pathol 1998;51:310-6.
5. Makamura S, Yatabe Y, Seto M. Cyclin D1 overexpression in malignant lymphomas. Pathol Int 1997;47:421-9.
6. Hui AM, Makuuchi M, Li X. Cell cycle regulators and human hepatocarcinogenesis. Hepatogastroenterology 1998;45:1635-42.
7. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, et al. Expression of cell cycle regulated proteins in prostate cancer. Cancer Res 1996;56:4159-63.
8. Dutta A, Chandra R, Leiter LM, Lester S. Cyclins as markers of tumor proliferation. Immunocytochemical studies in breast cancer. Proc Natl Acad Sci U S A 1995;92:5386-90.
9. Albers P, Ulbright TM, Albers J, Miller GA, Orazi A, Crabtree W, et al. Tumor proliferative activity is predictive of pathologic stage in clinical stage A nonseminomatous testicular germ cell tumors. J Urol 1996;155:579-86.
10. Moul JW, McCarthy WF, Fernandez EB, Sesterhenn IA. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res 1994;54:362-4.
11. Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998;83:1002-11.
12. Warde P, Gospodarowicz MK, Banerjee D, Panzarella T, Sugar L, Catton CN, et al. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 1997;157:1705-10.
13. Desdouets C, Sobczak-Thepot J, Murphy M, Brechot C. Cyclin A: function and expression during cell proliferation. Prog Cell Cycle Res 1995;1:115-23.
14. Sauer K, Lehner CF. The role of cyclin E in the regulation of entry into S phase. Prog Cell Cycle Res 1995;1:125-39.
15. Keyomarsi K, Herliczek TW. The role of cyclin E in cell proliferation, development, and cancer. Prog Cell Cycle Res 1997;3:171-91.
16. Quade BJ, Park JJ, Crum CP, Sun D, Dutta A. In vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998;11:1238-46.
17. Renshaw AA, Loughlin KR, Dutta A. Cyclin A and Mib1 (Ki-67) as markers for proliferative activity in primary renal neoplasms. Mod Pathol 1998;11:963-6.
18. Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, et al. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J Exp Ther Oncol 1996;1:88-94.
19. Furihata M, Ohtsuki Y, Sonobe H, Shuin T, Yamamoto A, Terao N, et al. Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter. Br J Cancer 1998;77:783-8.
20. Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, et al. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 1998;82:1238-43.
21. Scott KA, Walker RA. Lack of cyclin E reactivity in nonmalignant breast and association with proliferation in breast cancer. Br J Cancer 1997;76:1288-92.
22. Marone M, Scambia G, Giannitelle C, Ferrandina G, Masciullo V, Bellacosa A, et al. Analysis of cyclin E and Cdk2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer 1998;75:34-9.